Science news articles about 'prostate specific antigen test'

Although widespread Prostate-Specific-Antigen (PSA) testing has undoubtedly decreased prostate cancer ... 849 men (122 with and 727 without prostate cancer) with serial PSA measurements . Researchers ...

... for Cancer Research. Currently, the most common method for assessing risk for prostate cancer is the prostate specific antigen test, but this method can identify tumors that may not be a threat to ...

... -- an indicator that his cancer was growing and spreading and it was not responding to any drugs. A prostate-specific antigen test measures the amount of prostate-specific antigen in the blood. PSA ...

... -- about prostate cancer screening, asserting that the prostate-specific antigen test should be offered to well-informed, men aged 40 years or older who have a life expectancy of at ...

... pick up on the cancer tissue left behind. To test the idea, Presti and his colleagues analyzed ... unknown, leaving the actual sensitivity of the prostate-specific antigen test open to question. But, she ...

... data for men with localized T1 or T2 prostate cancer to evaluate the outcomes of conservatively managed ... grade migration, among other factors. Prostate-specific antigen testing identifies disease 6 ...

... half of at-risk men have a routine prostate-specific antigen test and 75 percent have previously ... actually pose minimal risk. A comparison of prostate cancer incidence rates in the U.S. to the United ...

... age 50 reported undergoing a prostate specific antigen test to detect prostate cancer in the previous year, yet only one in three young black men reported ever having a PSA test in the previous year.